Clinical Trial Update: BE Study of Naftifine HCL [Phase 3]

View source ↗

Summary

A Phase 3 bioequivalence study of naftifine hydrochloride for tinea pedis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Naftifine HCl (naftifine hydrochloride)

Snippet

Sponsor: Genzum Life Sciences | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED